![](/images/general/no_picture/200_user.png)
Daryl C Pope
Examiner (ID: 2421, Phone: (571)272-2959 , Office: P/2687 )
Most Active Art Unit | 2687 |
Art Unit(s) | 2735, 2736, 2617, 2612, 2685, 2754, 2687, 2632 |
Total Applications | 2954 |
Issued Applications | 2429 |
Pending Applications | 178 |
Abandoned Applications | 347 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1333282
[patent_doc_number] => 06596712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities'
[patent_app_type] => B2
[patent_app_number] => 09/803740
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 15524
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596712.pdf
[firstpage_image] =>[orig_patent_app_number] => 09803740
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/803740 | Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities | Mar 11, 2001 | Issued |
Array
(
[id] => 1388128
[patent_doc_number] => 06548488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-15
[patent_title] => 'Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer'
[patent_app_type] => B2
[patent_app_number] => 09/799615
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3039
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548488.pdf
[firstpage_image] =>[orig_patent_app_number] => 09799615
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/799615 | Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer | Mar 6, 2001 | Issued |
Array
(
[id] => 7079134
[patent_doc_number] => 20010041712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/799663
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3045
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041712.pdf
[firstpage_image] =>[orig_patent_app_number] => 09799663
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/799663 | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer | Mar 6, 2001 | Issued |
Array
(
[id] => 1325775
[patent_doc_number] => 06602910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-05
[patent_title] => 'D-enantiomer of DFMO and methods of use therefor'
[patent_app_type] => B2
[patent_app_number] => 09/801197
[patent_app_country] => US
[patent_app_date] => 2001-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 34
[patent_no_of_words] => 15019
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602910.pdf
[firstpage_image] =>[orig_patent_app_number] => 09801197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/801197 | D-enantiomer of DFMO and methods of use therefor | Mar 5, 2001 | Issued |
Array
(
[id] => 1341289
[patent_doc_number] => 06589981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-08
[patent_title] => 'Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/794417
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 9590
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589981.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794417 | Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives | Feb 26, 2001 | Issued |
Array
(
[id] => 5829265
[patent_doc_number] => 20020068743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/793520
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3132
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09793520
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/793520 | Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer | Feb 26, 2001 | Issued |
Array
(
[id] => 6934774
[patent_doc_number] => 20010056118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Novel compositions and uses of dictyostatin compounds'
[patent_app_type] => new
[patent_app_number] => 09/793323
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6938
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09793323
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/793323 | Compositions and uses of dictyostatin compounds | Feb 25, 2001 | Issued |
Array
(
[id] => 6896415
[patent_doc_number] => 20010027205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Pharmaceutical composition for and method of treating leukemia'
[patent_app_type] => new
[patent_app_number] => 09/792112
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7979
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027205.pdf
[firstpage_image] =>[orig_patent_app_number] => 09792112
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/792112 | Pharmaceutical composition for and method of treating leukemia | Feb 22, 2001 | Issued |
Array
(
[id] => 1418233
[patent_doc_number] => 06518298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-11
[patent_title] => 'Methods and compositions for inhibition of angiogenesis with EM-138'
[patent_app_type] => B2
[patent_app_number] => 09/788872
[patent_app_country] => US
[patent_app_date] => 2001-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 7894
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518298.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788872
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788872 | Methods and compositions for inhibition of angiogenesis with EM-138 | Feb 19, 2001 | Issued |
Array
(
[id] => 7094112
[patent_doc_number] => 20010034451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Phenyl-substituted 1,4-dihydropyridines'
[patent_app_type] => new
[patent_app_number] => 09/781516
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7135
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034451.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781516
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781516 | Phenyl-substituted 1,4-dihydropyridines | Feb 11, 2001 | Issued |
Array
(
[id] => 1265625
[patent_doc_number] => 06656509
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Combination of selenium-containing compounds with cytostatics'
[patent_app_type] => B1
[patent_app_number] => 09/701326
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8264
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701326
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701326 | Combination of selenium-containing compounds with cytostatics | Feb 1, 2001 | Issued |
Array
(
[id] => 6896420
[patent_doc_number] => 20010027210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Combination therapy for cancer'
[patent_app_type] => new
[patent_app_number] => 09/774002
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2621
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09774002
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/774002 | Combination therapy for cancer | Jan 30, 2001 | Issued |
Array
(
[id] => 7065619
[patent_doc_number] => 20010044465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-22
[patent_title] => 'Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity'
[patent_app_type] => new
[patent_app_number] => 09/769488
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13527
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20010044465.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769488
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769488 | Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity | Jan 25, 2001 | Issued |
Array
(
[id] => 6569371
[patent_doc_number] => 20020165261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders'
[patent_app_type] => new
[patent_app_number] => 09/768870
[patent_app_country] => US
[patent_app_date] => 2001-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10316
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165261.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768870
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768870 | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders | Jan 23, 2001 | Issued |
Array
(
[id] => 7015190
[patent_doc_number] => 20010051637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-13
[patent_title] => 'Indole derivatives as prodrugs of 5-HT1-like receptor agonists'
[patent_app_type] => new
[patent_app_number] => 09/759586
[patent_app_country] => US
[patent_app_date] => 2001-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4486
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20010051637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09759586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/759586 | Indole derivatives as prodrugs of 5-HT1-like receptor agonists | Jan 11, 2001 | Issued |
Array
(
[id] => 7065601
[patent_doc_number] => 20010044457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-22
[patent_title] => 'Cancer Treatment'
[patent_app_type] => new
[patent_app_number] => 09/758803
[patent_app_country] => US
[patent_app_date] => 2001-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7044
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20010044457.pdf
[firstpage_image] =>[orig_patent_app_number] => 09758803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/758803 | Cancer Treatment | Jan 10, 2001 | Abandoned |
Array
(
[id] => 1501013
[patent_doc_number] => 06486179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-26
[patent_title] => 'Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy'
[patent_app_type] => B2
[patent_app_number] => 09/758020
[patent_app_country] => US
[patent_app_date] => 2001-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5677
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/486/06486179.pdf
[firstpage_image] =>[orig_patent_app_number] => 09758020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/758020 | Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy | Jan 9, 2001 | Issued |
Array
(
[id] => 1240416
[patent_doc_number] => 06686391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions'
[patent_app_type] => B2
[patent_app_number] => 09/748652
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9875
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09748652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/748652 | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions | Dec 21, 2000 | Issued |
Array
(
[id] => 6875637
[patent_doc_number] => 20010000730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-03
[patent_title] => 'Method of enhancing the efficacy of anti-tumor agents'
[patent_app_type] => new-utility
[patent_app_number] => 09/740501
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4604
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0000/20010000730.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740501
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740501 | Method of enhancing the efficacy of anti-tumor agents | Dec 18, 2000 | Issued |
Array
(
[id] => 6898850
[patent_doc_number] => 20010047015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Pharmaceutical composition for inhibiting the growth of cancers'
[patent_app_type] => new
[patent_app_number] => 09/737835
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4163
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20010047015.pdf
[firstpage_image] =>[orig_patent_app_number] => 09737835
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/737835 | Pharmaceutical composition for inhibiting the growth of cancers | Dec 14, 2000 | Abandoned |